Assembly members held a committee hearing this week to talk about the technology’s impact on health equity and costs.

Repealing the Inflation Reduction Act could slow our ability to build more power generation and increase the risk of rolling ...

Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...

Detailed price information for Beam Therapeutics Inc (BEAM-Q) from The Globe and Mail including charting and trades.

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

As biometric and health-tracking technologies become more accessible, companies are increasingly collecting employees’ bodily ...

Future health risks will be determined not just by the ... an important opportunity for generating health and climate co-benefits. 32 Among foods, red meat results in the highest greenhouse ...

Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...